持仓坚赞 personal page - To The Moon

持仓坚赞

持仓坚赞

No personal profile

196Follow

7Followers

0Topic

0Badge

2021-05-17

$Altimeter Growth Corp.(AGC)$Holding with great patience. We know what it worth.

2021-05-29

good

Sorry, the original content has been removed

2021-04-23

$Altimeter Growth Corp.(AGC)$Patiently waiting for the merger completion.

2021-04-24

Get your Tesla EV car brake problems fixed first before talking about migration mankind to Mars, Mr Musk. [Tongue]

Sorry, the original content has been removed

2021-05-16

$Altimeter Growth Corp.(AGC)$Climbing out of the hole now...

2021-04-26

Going down trend from day one with record high 21Q1 earning. Something is going on?

2021-05-06

Ask China A-share investor what did they do?

Sorry, the original content has been removed

2021-05-02

So it says...but no guarantee given of course...[Smug]

3 Turnaround Stocks With 91% to 104% Upside, According to Wall Street

2021-04-24

500%+ in 3 weeks, penny stocks are like gold-digging. You either go broke or go rich.

2021-04-21

No one keeps going without losing steam. For USmarket, just buy & forget till your retirement.

Opinion: High-momentum stocks have been losing steam and this could be signaling a market top

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3581987432905129","uuid":"3581987432905129","gmtCreate":1618893408911,"gmtModify":1618902408917,"name":"持仓坚赞","pinyin":"ccjzchicangjianzan","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/8a3a4e9baafbb73e84285526f19d430d","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":7,"headSize":196,"tweetSize":0,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.05.30","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":154603755,"gmtCreate":1625514916277,"gmtModify":1703742812663,"author":{"id":"3581987432905129","authorId":"3581987432905129","name":"持仓坚赞","avatar":"https://static.tigerbbs.com/8a3a4e9baafbb73e84285526f19d430d","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581987432905129","idStr":"3581987432905129"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ONTX\">$Onconova Therapeutics, Inc.(ONTX)$</a>Getting sh*trier &amp; sh*ttier.","listText":"<a href=\"https://laohu8.com/S/ONTX\">$Onconova Therapeutics, Inc.(ONTX)$</a>Getting sh*trier &amp; sh*ttier.","text":"$Onconova Therapeutics, Inc.(ONTX)$Getting sh*trier & sh*ttier.","images":[{"img":"https://static.tigerbbs.com/8f4849cf3e808bfcbd184acf3f1d54ff","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/154603755","isVote":1,"tweetType":1,"viewCount":2956,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":115397159,"gmtCreate":1622949890371,"gmtModify":1704193652248,"author":{"id":"3581987432905129","authorId":"3581987432905129","name":"持仓坚赞","avatar":"https://static.tigerbbs.com/8a3a4e9baafbb73e84285526f19d430d","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581987432905129","idStr":"3581987432905129"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AGC\">$Altimeter Growth Corp.(AGC)$</a>Hovering around a small range of price for accumulation purpose.","listText":"<a href=\"https://laohu8.com/S/AGC\">$Altimeter Growth Corp.(AGC)$</a>Hovering around a small range of price for accumulation purpose.","text":"$Altimeter Growth Corp.(AGC)$Hovering around a small range of price for accumulation purpose.","images":[{"img":"https://static.tigerbbs.com/5a8d1fd54fece7f7806c15973c602870","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/115397159","isVote":1,"tweetType":1,"viewCount":2859,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":116248455,"gmtCreate":1622807378777,"gmtModify":1704191549025,"author":{"id":"3581987432905129","authorId":"3581987432905129","name":"持仓坚赞","avatar":"https://static.tigerbbs.com/8a3a4e9baafbb73e84285526f19d430d","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581987432905129","idStr":"3581987432905129"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AGC\">$Altimeter Growth Corp.(AGC)$</a>[Spurting]&nbsp;[Spurting]&nbsp;[Spurting]&nbsp;[Spurting]&nbsp;[Spurting]&nbsp;","listText":"<a href=\"https://laohu8.com/S/AGC\">$Altimeter Growth Corp.(AGC)$</a>[Spurting]&nbsp;[Spurting]&nbsp;[Spurting]&nbsp;[Spurting]&nbsp;[Spurting]&nbsp;","text":"$Altimeter Growth Corp.(AGC)$[Spurting] [Spurting] [Spurting] [Spurting] [Spurting]","images":[{"img":"https://static.tigerbbs.com/8e22f94df468f1f92c1ce92be3e18cfd","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/116248455","isVote":1,"tweetType":1,"viewCount":3024,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":116241292,"gmtCreate":1622807337116,"gmtModify":1704191547408,"author":{"id":"3581987432905129","authorId":"3581987432905129","name":"持仓坚赞","avatar":"https://static.tigerbbs.com/8a3a4e9baafbb73e84285526f19d430d","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581987432905129","idStr":"3581987432905129"},"themes":[],"htmlText":"Another AMC kind of move?","listText":"Another AMC kind of move?","text":"Another AMC kind of move?","images":[{"img":"https://static.tigerbbs.com/95aa239e0c722a12babf5af45c5ebf38","width":"750","height":"1679"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/116241292","isVote":1,"tweetType":1,"viewCount":2661,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":118635884,"gmtCreate":1622729904948,"gmtModify":1704189987756,"author":{"id":"3581987432905129","authorId":"3581987432905129","name":"持仓坚赞","avatar":"https://static.tigerbbs.com/8a3a4e9baafbb73e84285526f19d430d","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581987432905129","idStr":"3581987432905129"},"themes":[],"htmlText":"Legalisation will really be a game changer?&nbsp;","listText":"Legalisation will really be a game changer?&nbsp;","text":"Legalisation will really be a game changer?","images":[{"img":"https://static.tigerbbs.com/00b70a2afeea7d8d9b4ed449185c12de","width":"750","height":"1616"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/118635884","isVote":1,"tweetType":1,"viewCount":2288,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":118636540,"gmtCreate":1622729845680,"gmtModify":1704189985425,"author":{"id":"3581987432905129","authorId":"3581987432905129","name":"持仓坚赞","avatar":"https://static.tigerbbs.com/8a3a4e9baafbb73e84285526f19d430d","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581987432905129","idStr":"3581987432905129"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AGC\">$Altimeter Growth Corp.(AGC)$</a>No sign of takingoff at all. The pilot is at vacation.","listText":"<a href=\"https://laohu8.com/S/AGC\">$Altimeter Growth Corp.(AGC)$</a>No sign of takingoff at all. The pilot is at vacation.","text":"$Altimeter Growth Corp.(AGC)$No sign of takingoff at all. The pilot is at vacation.","images":[{"img":"https://static.tigerbbs.com/350cceeab1620fe7cced95ae099ee439","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/118636540","isVote":1,"tweetType":1,"viewCount":2316,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":134753200,"gmtCreate":1622261911900,"gmtModify":1704182460695,"author":{"id":"3581987432905129","authorId":"3581987432905129","name":"持仓坚赞","avatar":"https://static.tigerbbs.com/8a3a4e9baafbb73e84285526f19d430d","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581987432905129","idStr":"3581987432905129"},"themes":[],"htmlText":"good","listText":"good","text":"good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/134753200","repostId":"2138488761","repostType":4,"isVote":1,"tweetType":1,"viewCount":3709,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":135798448,"gmtCreate":1622182102684,"gmtModify":1704181033227,"author":{"id":"3581987432905129","authorId":"3581987432905129","name":"持仓坚赞","avatar":"https://static.tigerbbs.com/8a3a4e9baafbb73e84285526f19d430d","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581987432905129","idStr":"3581987432905129"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AGC\">$Altimeter Growth Corp.(AGC)$</a>Getting there some day.&nbsp;","listText":"<a href=\"https://laohu8.com/S/AGC\">$Altimeter Growth Corp.(AGC)$</a>Getting there some day.&nbsp;","text":"$Altimeter Growth Corp.(AGC)$Getting there some day.","images":[{"img":"https://static.tigerbbs.com/b43b528d2380fbcef664044120c83342","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/135798448","isVote":1,"tweetType":1,"viewCount":2739,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":135791419,"gmtCreate":1622182011431,"gmtModify":1704181031111,"author":{"id":"3581987432905129","authorId":"3581987432905129","name":"持仓坚赞","avatar":"https://static.tigerbbs.com/8a3a4e9baafbb73e84285526f19d430d","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581987432905129","idStr":"3581987432905129"},"themes":[],"htmlText":"Feeling more and more like a scam company...","listText":"Feeling more and more like a scam company...","text":"Feeling more and more like a scam company...","images":[{"img":"https://static.tigerbbs.com/bc6c1551011b3de69d9e000a900e99ef","width":"750","height":"1733"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/135791419","isVote":1,"tweetType":1,"viewCount":2852,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":133860100,"gmtCreate":1621735604800,"gmtModify":1704361855099,"author":{"id":"3581987432905129","authorId":"3581987432905129","name":"持仓坚赞","avatar":"https://static.tigerbbs.com/8a3a4e9baafbb73e84285526f19d430d","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581987432905129","idStr":"3581987432905129"},"themes":[],"htmlText":"Potential growth of UGC market in covid era.","listText":"Potential growth of UGC market in covid era.","text":"Potential growth of UGC market in covid era.","images":[{"img":"https://static.tigerbbs.com/7210a45f348ee328b4144d637b185465","width":"750","height":"1570"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/133860100","isVote":1,"tweetType":1,"viewCount":2894,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":130684632,"gmtCreate":1621536664826,"gmtModify":1704359250102,"author":{"id":"3581987432905129","authorId":"3581987432905129","name":"持仓坚赞","avatar":"https://static.tigerbbs.com/8a3a4e9baafbb73e84285526f19d430d","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581987432905129","idStr":"3581987432905129"},"themes":[],"htmlText":"Will&nbsp;crypto bubbles bursting have an impact to the Q2 &amp; FY&nbsp;earning?&nbsp;","listText":"Will&nbsp;crypto bubbles bursting have an impact to the Q2 &amp; FY&nbsp;earning?&nbsp;","text":"Will crypto bubbles bursting have an impact to the Q2 & FY earning?","images":[{"img":"https://static.tigerbbs.com/67e61051fdb79c9350d9ae5d40502c2b","width":"750","height":"1616"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/130684632","isVote":1,"tweetType":1,"viewCount":1004,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":197008223,"gmtCreate":1621407025362,"gmtModify":1704357119688,"author":{"id":"3581987432905129","authorId":"3581987432905129","name":"持仓坚赞","avatar":"https://static.tigerbbs.com/8a3a4e9baafbb73e84285526f19d430d","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581987432905129","idStr":"3581987432905129"},"themes":[],"htmlText":"Shaping up with all technical indicators.&nbsp;","listText":"Shaping up with all technical indicators.&nbsp;","text":"Shaping up with all technical indicators.","images":[{"img":"https://static.tigerbbs.com/84bfea8f1dfa013f849e07c2642060cb","width":"750","height":"1733"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/197008223","isVote":1,"tweetType":1,"viewCount":974,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":195451271,"gmtCreate":1621310448693,"gmtModify":1704355575933,"author":{"id":"3581987432905129","authorId":"3581987432905129","name":"持仓坚赞","avatar":"https://static.tigerbbs.com/8a3a4e9baafbb73e84285526f19d430d","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581987432905129","idStr":"3581987432905129"},"themes":[],"htmlText":"Back to where it came from before next cycle of pump and dump.&nbsp;","listText":"Back to where it came from before next cycle of pump and dump.&nbsp;","text":"Back to where it came from before next cycle of pump and dump.","images":[{"img":"https://static.tigerbbs.com/a10699c623dbbfe53111513e31ba258c","width":"750","height":"1788"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/195451271","isVote":1,"tweetType":1,"viewCount":954,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":195091494,"gmtCreate":1621237293618,"gmtModify":1704354415641,"author":{"id":"3581987432905129","authorId":"3581987432905129","name":"持仓坚赞","avatar":"https://static.tigerbbs.com/8a3a4e9baafbb73e84285526f19d430d","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581987432905129","idStr":"3581987432905129"},"themes":[],"htmlText":"Resurrection of Covid test at airport?&nbsp;","listText":"Resurrection of Covid test at airport?&nbsp;","text":"Resurrection of Covid test at airport?","images":[{"img":"https://static.tigerbbs.com/0c2d1dbc1436c5e2e0545c40631fc836","width":"750","height":"1570"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/195091494","isVote":1,"tweetType":1,"viewCount":1150,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":195091981,"gmtCreate":1621237212143,"gmtModify":1704354414815,"author":{"id":"3581987432905129","authorId":"3581987432905129","name":"持仓坚赞","avatar":"https://static.tigerbbs.com/8a3a4e9baafbb73e84285526f19d430d","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581987432905129","idStr":"3581987432905129"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AGC\">$Altimeter Growth Corp.(AGC)$</a>Holding with great patience. We know what it worth.","listText":"<a href=\"https://laohu8.com/S/AGC\">$Altimeter Growth Corp.(AGC)$</a>Holding with great patience. We know what it worth.","text":"$Altimeter Growth Corp.(AGC)$Holding with great patience. We know what it worth.","images":[{"img":"https://static.tigerbbs.com/8e22f94df468f1f92c1ce92be3e18cfd","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":7,"repostSize":0,"link":"https://ttm.financial/post/195091981","isVote":1,"tweetType":1,"viewCount":1861,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3574990639131991","authorId":"3574990639131991","name":"绿叶蔬菜","avatar":"https://static.tigerbbs.com/8167629ddd2bdce471d9d90cbc5caf2d","crmLevel":11,"crmLevelSwitch":1,"authorIdStr":"3574990639131991","idStr":"3574990639131991"},"content":"one more lockdown and Grab will show it's worth!","text":"one more lockdown and Grab will show it's worth!","html":"one more lockdown and Grab will show it's worth!"},{"author":{"id":"3581834394794992","authorId":"3581834394794992","name":"TitaniumHand","avatar":"https://static.tigerbbs.com/a1ca83497519f3c7cb442d6450a81fd2","crmLevel":11,"crmLevelSwitch":0,"authorIdStr":"3581834394794992","idStr":"3581834394794992"},"content":"Good lied to yourself !","text":"Good lied to yourself !","html":"Good lied to yourself !"}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":192157894,"gmtCreate":1621168217318,"gmtModify":1704353556131,"author":{"id":"3581987432905129","authorId":"3581987432905129","name":"持仓坚赞","avatar":"https://static.tigerbbs.com/8a3a4e9baafbb73e84285526f19d430d","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581987432905129","idStr":"3581987432905129"},"themes":[],"htmlText":"Here we go again.&nbsp;","listText":"Here we go again.&nbsp;","text":"Here we go again.","images":[{"img":"https://static.tigerbbs.com/3b3c02e0f41d73198d6bcd813da04075","width":"750","height":"1570"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/192157894","isVote":1,"tweetType":1,"viewCount":1033,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":192157110,"gmtCreate":1621168169630,"gmtModify":1704353555643,"author":{"id":"3581987432905129","authorId":"3581987432905129","name":"持仓坚赞","avatar":"https://static.tigerbbs.com/8a3a4e9baafbb73e84285526f19d430d","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581987432905129","idStr":"3581987432905129"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AGC\">$Altimeter Growth Corp.(AGC)$</a>Climbing out of the hole&nbsp;now...","listText":"<a href=\"https://laohu8.com/S/AGC\">$Altimeter Growth Corp.(AGC)$</a>Climbing out of the hole&nbsp;now...","text":"$Altimeter Growth Corp.(AGC)$Climbing out of the hole now...","images":[{"img":"https://static.tigerbbs.com/8e22f94df468f1f92c1ce92be3e18cfd","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/192157110","isVote":1,"tweetType":1,"viewCount":1599,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3577190140208028","authorId":"3577190140208028","name":"Officer","avatar":"https://static.tigerbbs.com/ed97e5216aa01d2c4c7fa27cb2d55ebf","crmLevel":11,"crmLevelSwitch":0,"authorIdStr":"3577190140208028","idStr":"3577190140208028"},"content":"Dun give up. Fight !!","text":"Dun give up. Fight !!","html":"Dun give up. Fight !!"}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":190432253,"gmtCreate":1620642365772,"gmtModify":1704345983648,"author":{"id":"3581987432905129","authorId":"3581987432905129","name":"持仓坚赞","avatar":"https://static.tigerbbs.com/8a3a4e9baafbb73e84285526f19d430d","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581987432905129","idStr":"3581987432905129"},"themes":[],"htmlText":"It is getting exciting now...","listText":"It is getting exciting now...","text":"It is getting exciting now...","images":[{"img":"https://static.tigerbbs.com/a07a6dd3a66d673a79eb3843b06e3ea4","width":"750","height":"1733"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/190432253","isVote":1,"tweetType":1,"viewCount":1016,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":107298171,"gmtCreate":1620493738493,"gmtModify":1704344340842,"author":{"id":"3581987432905129","authorId":"3581987432905129","name":"持仓坚赞","avatar":"https://static.tigerbbs.com/8a3a4e9baafbb73e84285526f19d430d","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581987432905129","idStr":"3581987432905129"},"themes":[],"htmlText":"Adrenaline pumping stocks require a strong heart[Spurting]&nbsp;","listText":"Adrenaline pumping stocks require a strong heart[Spurting]&nbsp;","text":"Adrenaline pumping stocks require a strong heart[Spurting]","images":[{"img":"https://static.tigerbbs.com/03183f06c7d6134dda81b94da3a34648","width":"750","height":"1570"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/107298171","isVote":1,"tweetType":1,"viewCount":1008,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":107298902,"gmtCreate":1620493661806,"gmtModify":1704344340678,"author":{"id":"3581987432905129","authorId":"3581987432905129","name":"持仓坚赞","avatar":"https://static.tigerbbs.com/8a3a4e9baafbb73e84285526f19d430d","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581987432905129","idStr":"3581987432905129"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AGC\">$Altimeter Growth Corp.(AGC)$</a>Poke&nbsp;Guy...[Grin]&nbsp;[Grin]&nbsp;[Grin]&nbsp;","listText":"<a href=\"https://laohu8.com/S/AGC\">$Altimeter Growth Corp.(AGC)$</a>Poke&nbsp;Guy...[Grin]&nbsp;[Grin]&nbsp;[Grin]&nbsp;","text":"$Altimeter Growth Corp.(AGC)$Poke Guy...[Grin] [Grin] [Grin]","images":[{"img":"https://static.tigerbbs.com/a8545df14b16e4c07cebd7450447c645","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/107298902","isVote":1,"tweetType":1,"viewCount":824,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"hots":[{"id":195091981,"gmtCreate":1621237212143,"gmtModify":1704354414815,"author":{"id":"3581987432905129","authorId":"3581987432905129","name":"持仓坚赞","avatar":"https://static.tigerbbs.com/8a3a4e9baafbb73e84285526f19d430d","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581987432905129","authorIdStr":"3581987432905129"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AGC\">$Altimeter Growth Corp.(AGC)$</a>Holding with great patience. We know what it worth.","listText":"<a href=\"https://laohu8.com/S/AGC\">$Altimeter Growth Corp.(AGC)$</a>Holding with great patience. We know what it worth.","text":"$Altimeter Growth Corp.(AGC)$Holding with great patience. We know what it worth.","images":[{"img":"https://static.tigerbbs.com/8e22f94df468f1f92c1ce92be3e18cfd","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":7,"repostSize":0,"link":"https://ttm.financial/post/195091981","isVote":1,"tweetType":1,"viewCount":1861,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3574990639131991","authorId":"3574990639131991","name":"绿叶蔬菜","avatar":"https://static.tigerbbs.com/8167629ddd2bdce471d9d90cbc5caf2d","crmLevel":11,"crmLevelSwitch":1,"idStr":"3574990639131991","authorIdStr":"3574990639131991"},"content":"one more lockdown and Grab will show it's worth!","text":"one more lockdown and Grab will show it's worth!","html":"one more lockdown and Grab will show it's worth!"},{"author":{"id":"3581834394794992","authorId":"3581834394794992","name":"TitaniumHand","avatar":"https://static.tigerbbs.com/a1ca83497519f3c7cb442d6450a81fd2","crmLevel":11,"crmLevelSwitch":0,"idStr":"3581834394794992","authorIdStr":"3581834394794992"},"content":"Good lied to yourself !","text":"Good lied to yourself !","html":"Good lied to yourself !"}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":134753200,"gmtCreate":1622261911900,"gmtModify":1704182460695,"author":{"id":"3581987432905129","authorId":"3581987432905129","name":"持仓坚赞","avatar":"https://static.tigerbbs.com/8a3a4e9baafbb73e84285526f19d430d","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581987432905129","authorIdStr":"3581987432905129"},"themes":[],"htmlText":"good","listText":"good","text":"good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/134753200","repostId":"2138488761","repostType":4,"isVote":1,"tweetType":1,"viewCount":3709,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":372078991,"gmtCreate":1619164346613,"gmtModify":1704720617338,"author":{"id":"3581987432905129","authorId":"3581987432905129","name":"持仓坚赞","avatar":"https://static.tigerbbs.com/8a3a4e9baafbb73e84285526f19d430d","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581987432905129","authorIdStr":"3581987432905129"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AGC\">$Altimeter Growth Corp.(AGC)$</a>Patiently waiting for the merger completion.","listText":"<a href=\"https://laohu8.com/S/AGC\">$Altimeter Growth Corp.(AGC)$</a>Patiently waiting for the merger completion.","text":"$Altimeter Growth Corp.(AGC)$Patiently waiting for the merger completion.","images":[{"img":"https://static.tigerbbs.com/0174cc95394b3f4e358455814837e8de","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":4,"repostSize":0,"link":"https://ttm.financial/post/372078991","isVote":1,"tweetType":1,"viewCount":1773,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3579512222503952","authorId":"3579512222503952","name":"soyabeanken","avatar":"https://static.tigerbbs.com/0f789d2fa21cb60a325d16052a8389d8","crmLevel":11,"crmLevelSwitch":0,"idStr":"3579512222503952","authorIdStr":"3579512222503952"},"content":"any idea when is the merger?","text":"any idea when is the merger?","html":"any idea when is the merger?"}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":372661233,"gmtCreate":1619203658422,"gmtModify":1704721247477,"author":{"id":"3581987432905129","authorId":"3581987432905129","name":"持仓坚赞","avatar":"https://static.tigerbbs.com/8a3a4e9baafbb73e84285526f19d430d","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581987432905129","authorIdStr":"3581987432905129"},"themes":[],"htmlText":"Get your&nbsp;Tesla EV car brake problems&nbsp;fixed first before talking about migration mankind&nbsp;to Mars, Mr Musk. [Tongue]&nbsp;","listText":"Get your&nbsp;Tesla EV car brake problems&nbsp;fixed first before talking about migration mankind&nbsp;to Mars, Mr Musk. [Tongue]&nbsp;","text":"Get your Tesla EV car brake problems fixed first before talking about migration mankind to Mars, Mr Musk. [Tongue]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/372661233","repostId":"1149578575","repostType":4,"isVote":1,"tweetType":1,"viewCount":1193,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":192157110,"gmtCreate":1621168169630,"gmtModify":1704353555643,"author":{"id":"3581987432905129","authorId":"3581987432905129","name":"持仓坚赞","avatar":"https://static.tigerbbs.com/8a3a4e9baafbb73e84285526f19d430d","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581987432905129","authorIdStr":"3581987432905129"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AGC\">$Altimeter Growth Corp.(AGC)$</a>Climbing out of the hole&nbsp;now...","listText":"<a href=\"https://laohu8.com/S/AGC\">$Altimeter Growth Corp.(AGC)$</a>Climbing out of the hole&nbsp;now...","text":"$Altimeter Growth Corp.(AGC)$Climbing out of the hole now...","images":[{"img":"https://static.tigerbbs.com/8e22f94df468f1f92c1ce92be3e18cfd","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/192157110","isVote":1,"tweetType":1,"viewCount":1599,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3577190140208028","authorId":"3577190140208028","name":"Officer","avatar":"https://static.tigerbbs.com/ed97e5216aa01d2c4c7fa27cb2d55ebf","crmLevel":11,"crmLevelSwitch":0,"idStr":"3577190140208028","authorIdStr":"3577190140208028"},"content":"Dun give up. Fight !!","text":"Dun give up. Fight !!","html":"Dun give up. Fight !!"}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":375578640,"gmtCreate":1619374920780,"gmtModify":1704722931975,"author":{"id":"3581987432905129","authorId":"3581987432905129","name":"持仓坚赞","avatar":"https://static.tigerbbs.com/8a3a4e9baafbb73e84285526f19d430d","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581987432905129","authorIdStr":"3581987432905129"},"themes":[],"htmlText":"Going down trend from day one with record high&nbsp;21Q1 earning. Something is going on?","listText":"Going down trend from day one with record high&nbsp;21Q1 earning. Something is going on?","text":"Going down trend from day one with record high 21Q1 earning. Something is going on?","images":[{"img":"https://static.tigerbbs.com/ab87df3637d3ef84ca82464c45b46ebc","width":"750","height":"1570"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/375578640","isVote":1,"tweetType":1,"viewCount":711,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3581577471479869","authorId":"3581577471479869","name":"嘉仓佑措","avatar":"https://static.tigerbbs.com/0d21c8840621f4fb6dfb0bdf7fcb7759","crmLevel":11,"crmLevelSwitch":0,"idStr":"3581577471479869","authorIdStr":"3581577471479869"},"content":"I’m sticking to long term play on this one.","text":"I’m sticking to long term play on this one.","html":"I’m sticking to long term play on this one."}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":105231287,"gmtCreate":1620304924049,"gmtModify":1704341633341,"author":{"id":"3581987432905129","authorId":"3581987432905129","name":"持仓坚赞","avatar":"https://static.tigerbbs.com/8a3a4e9baafbb73e84285526f19d430d","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581987432905129","authorIdStr":"3581987432905129"},"themes":[],"htmlText":"Ask China A-share investor what did they do?&nbsp;","listText":"Ask China A-share investor what did they do?&nbsp;","text":"Ask China A-share investor what did they do?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/105231287","repostId":"2133387578","repostType":4,"isVote":1,"tweetType":1,"viewCount":918,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":101774227,"gmtCreate":1619953198869,"gmtModify":1704336734460,"author":{"id":"3581987432905129","authorId":"3581987432905129","name":"持仓坚赞","avatar":"https://static.tigerbbs.com/8a3a4e9baafbb73e84285526f19d430d","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581987432905129","authorIdStr":"3581987432905129"},"themes":[],"htmlText":"So it says...but no guarantee given of course...[Smug]&nbsp;","listText":"So it says...but no guarantee given of course...[Smug]&nbsp;","text":"So it says...but no guarantee given of course...[Smug]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/101774227","repostId":"1165708828","repostType":4,"repost":{"id":"1165708828","kind":"news","pubTimestamp":1619792862,"share":"https://ttm.financial/m/news/1165708828?lang=en_US&edition=fundamental","pubTime":"2021-04-30 22:27","market":"us","language":"en","title":"3 Turnaround Stocks With 91% to 104% Upside, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=1165708828","media":"Motley Fool","summary":"For more than a year, patient investors have been handsomely rewarded. All three of the market's maj","content":"<p>For more than a year, patient investors have been handsomely rewarded. All three of the market's major indexes have gained between 83% and 106% since hitting the bear-market bottom set on March 23, 2020.</p>\n<p>Yet, not all stocks have participated in the rally. Over the trailing year (through April 27, 2021), around 110 stocks with at least a $300 million market cap have declined by 20% (or more). Given the aforementioned big gains in the<b>S&amp;P 500</b>,<b>Dow Jones Industrial Average</b>, and<b>Nasdaq Composite</b>, this represents a huge underperformance.</p>\n<p>But according to analysts on Wall Street, some of these underperformers have a good chance to bounce back in a big way over the coming year. Based on consensus one-year price targets, the following three turnaround stocks offer upside ranging from 91% to as much as 104%.</p>\n<p>Sarepta Therapeutics: Implied upside of 91%</p>\n<p>Many of the worst-performing equities over the past year arebiotech stocks. With investors rolling the dice on future clinical outcomes, trial data announcements can yield wild price swings for drug developers. Shareholders of specialized drug developer<b>Sarepta Therapeutics</b>(NASDAQ:SRPT)learned this in January when shares of the company were halved in a day. But if Wall Street's one-year price target is correct, Sarepta could recoup most of its losses by gaining 91% from its April 27 close.</p>\n<p>Sarepta's bread and butter is its research in treating Duchenne Muscular Dystrophy (DMD). DMD is an incurable disease diagnosed in children that leads to the destruction of muscle and causes premature death. To date, the company has had the U.S. Food and Drug Administration (FDA) approve three of its gene-specific DMD treatments, which are designed to increase the production of dystrophin.</p>\n<p>However, themake-or-break treatmentin the company's pipeline is SRP-9001. This is an experimental treatment that utilizes an adeno-associated virus to deliver a gene to muscle tissue that \"programs\" for micro-dystrophin production.&nbsp; In other words, SRP-9001 would allow the company to treat a much larger percentage of DMD patients.</p>\n<p>The Part 1 data release of Study 102 evaluating SRP-9001 in DMD patients aged 4 to 7 is why the stock was halved in January. Although treated participants showed an increase in their North Star Ambulatory Assessment (NSAA) total score,it wasn't statistically significant. Sarepta, however, blamed this disappointment on fitness differences in its patients during the study and expects a much different outcome in the latter half of this study. Part 2 of Study 102 is, therefore, Sarepta's make-or-break DMD moment.</p>\n<p>Intercept Pharmaceuticals: Implied upside of 97%</p>\n<p>If you wanteven more upside potential, Wall Street would steer you toward small-cap<b>Intercept Pharmaceuticals</b>(NASDAQ:ICPT). Among the 4,000-plus securities with at least a $300 million market cap, it holds the distinction of being the absolute worst performer over the trailing year (down 75%). The only solace is that Wall Street's consensus price target would see Intercept gain 97% over the coming year.</p>\n<p>Similar to Sarepta, Intercept's future predominantly lies with one indication: nonalcoholic steatohepatitis, or NASH. NASH is a liver disease that affects between 2% and 5% of the U.S. adult population and has no FDA-approved cure. It can lead to fibrosis, liver cancer, and even death. It's been estimated that NASH represents a $35 billion treatment opportunity.</p>\n<p>Intercept is at the forefront of that opportunity, but it's not been without its hiccups. Experimental treatment obeticholic acid (OCA)met one of its two co-primary endpointsin the phase 3 Regenerate study -- a statistically significant reduction in liver fibrosis without a worsening in NASH. Only one met endpoint was needed to declare the trial a success.</p>\n<p>On the other hand, the highest dose (also the most effective) led to considerably higher instances of pruritus (itching) and trial discontinuation, relative to the placebo. Perhaps unsurprisingly, Interceptreceived a Complete Response Letterfrom the FDA following its new drug application to supply additional safety data.</p>\n<p>If OCA were to be approved, even for a small subset of the sickest patients, it would represent a greater than $1 billion sales opportunity.</p>\n<p>It's also worth noting that OCA is already approved under the brand name Ocaliva as a treatment for primary biliary cholangitis (PBC). With Ocaliva's PBC sales expected to hit at least $325 million in 2021 (nearly half the company's market cap), investors look to begetting a shot at NASH success nearly for free.</p>\n<p>Inovio Pharmaceuticals: Implied upside of 104%</p>\n<p>Yet another biotech stock withbig-time upside potential, according to Wall Street, is<b>Inovio Pharmaceuticals</b>(NASDAQ:INO). Shares of the company have been clobbered recently, but are expected to rally by 104% to nearly $15 based on the consensus 12-month price target of analysts.</p>\n<p>For much of the past year, the promise and peril of Inovio have rested with its development of a coronavirus disease 2019 (COVID-19) vaccine. The company's candidate, INO-4800, achieved immunological responses in 38 of 38 patients in phase 1 studies and looked to be on track to be among the roughly six or so early contenders to bring a COVID-19 vaccine to market in the United States.</p>\n<p>Unfortunately, Inovio's phase 2 and 3 studies hit a snag. The FDA placed a partial clinical hold on both phases and requested additional information concerning INO-4800 and the company's Cellectra delivery device. Cellectra uses electrical impulses to open pores in cells to allow plasmids to enter. Though the partial hold on the phase 2 study was lifted, the company has yet to run an all-important phase 3 study and may choose to do so outside the United States. To top things off, the U.S. Department of Defense notified Inovio that it wouldno longer be providing funding for its phase 3 study.</p>\n<p>There are two very big problems here. First, Inovio is running out of time to become a major player in treating COVID-19. The U.S. vaccination campaign will likely be complete sometime in July, and major players like<b>Johnson &amp; Johnson</b>&nbsp;can produce up to 3 billion doses for the global market this year. As a reminder, J&amp;J's vaccine is a single-dose treatment.</p>\n<p>The other potential red flag isInovio's track record. The company may have an intriguing delivery device in Cellectra, as well as nearly a dozen unique compounds in clinical trials, but it's yet to have the FDA approve any of its experimental treatments in four decades.</p>\n<p>With a number of its studies partnered, it's always possible Inovio could turn itself around. But given its track record, it may be best off avoided.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Turnaround Stocks With 91% to 104% Upside, According to Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Turnaround Stocks With 91% to 104% Upside, According to Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-30 22:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/30/3-turnaround-stocks-91-to-104-upside-wall-street/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>For more than a year, patient investors have been handsomely rewarded. All three of the market's major indexes have gained between 83% and 106% since hitting the bear-market bottom set on March 23, ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/30/3-turnaround-stocks-91-to-104-upside-wall-street/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/04/30/3-turnaround-stocks-91-to-104-upside-wall-street/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1165708828","content_text":"For more than a year, patient investors have been handsomely rewarded. All three of the market's major indexes have gained between 83% and 106% since hitting the bear-market bottom set on March 23, 2020.\nYet, not all stocks have participated in the rally. Over the trailing year (through April 27, 2021), around 110 stocks with at least a $300 million market cap have declined by 20% (or more). Given the aforementioned big gains in theS&P 500,Dow Jones Industrial Average, andNasdaq Composite, this represents a huge underperformance.\nBut according to analysts on Wall Street, some of these underperformers have a good chance to bounce back in a big way over the coming year. Based on consensus one-year price targets, the following three turnaround stocks offer upside ranging from 91% to as much as 104%.\nSarepta Therapeutics: Implied upside of 91%\nMany of the worst-performing equities over the past year arebiotech stocks. With investors rolling the dice on future clinical outcomes, trial data announcements can yield wild price swings for drug developers. Shareholders of specialized drug developerSarepta Therapeutics(NASDAQ:SRPT)learned this in January when shares of the company were halved in a day. But if Wall Street's one-year price target is correct, Sarepta could recoup most of its losses by gaining 91% from its April 27 close.\nSarepta's bread and butter is its research in treating Duchenne Muscular Dystrophy (DMD). DMD is an incurable disease diagnosed in children that leads to the destruction of muscle and causes premature death. To date, the company has had the U.S. Food and Drug Administration (FDA) approve three of its gene-specific DMD treatments, which are designed to increase the production of dystrophin.\nHowever, themake-or-break treatmentin the company's pipeline is SRP-9001. This is an experimental treatment that utilizes an adeno-associated virus to deliver a gene to muscle tissue that \"programs\" for micro-dystrophin production.  In other words, SRP-9001 would allow the company to treat a much larger percentage of DMD patients.\nThe Part 1 data release of Study 102 evaluating SRP-9001 in DMD patients aged 4 to 7 is why the stock was halved in January. Although treated participants showed an increase in their North Star Ambulatory Assessment (NSAA) total score,it wasn't statistically significant. Sarepta, however, blamed this disappointment on fitness differences in its patients during the study and expects a much different outcome in the latter half of this study. Part 2 of Study 102 is, therefore, Sarepta's make-or-break DMD moment.\nIntercept Pharmaceuticals: Implied upside of 97%\nIf you wanteven more upside potential, Wall Street would steer you toward small-capIntercept Pharmaceuticals(NASDAQ:ICPT). Among the 4,000-plus securities with at least a $300 million market cap, it holds the distinction of being the absolute worst performer over the trailing year (down 75%). The only solace is that Wall Street's consensus price target would see Intercept gain 97% over the coming year.\nSimilar to Sarepta, Intercept's future predominantly lies with one indication: nonalcoholic steatohepatitis, or NASH. NASH is a liver disease that affects between 2% and 5% of the U.S. adult population and has no FDA-approved cure. It can lead to fibrosis, liver cancer, and even death. It's been estimated that NASH represents a $35 billion treatment opportunity.\nIntercept is at the forefront of that opportunity, but it's not been without its hiccups. Experimental treatment obeticholic acid (OCA)met one of its two co-primary endpointsin the phase 3 Regenerate study -- a statistically significant reduction in liver fibrosis without a worsening in NASH. Only one met endpoint was needed to declare the trial a success.\nOn the other hand, the highest dose (also the most effective) led to considerably higher instances of pruritus (itching) and trial discontinuation, relative to the placebo. Perhaps unsurprisingly, Interceptreceived a Complete Response Letterfrom the FDA following its new drug application to supply additional safety data.\nIf OCA were to be approved, even for a small subset of the sickest patients, it would represent a greater than $1 billion sales opportunity.\nIt's also worth noting that OCA is already approved under the brand name Ocaliva as a treatment for primary biliary cholangitis (PBC). With Ocaliva's PBC sales expected to hit at least $325 million in 2021 (nearly half the company's market cap), investors look to begetting a shot at NASH success nearly for free.\nInovio Pharmaceuticals: Implied upside of 104%\nYet another biotech stock withbig-time upside potential, according to Wall Street, isInovio Pharmaceuticals(NASDAQ:INO). Shares of the company have been clobbered recently, but are expected to rally by 104% to nearly $15 based on the consensus 12-month price target of analysts.\nFor much of the past year, the promise and peril of Inovio have rested with its development of a coronavirus disease 2019 (COVID-19) vaccine. The company's candidate, INO-4800, achieved immunological responses in 38 of 38 patients in phase 1 studies and looked to be on track to be among the roughly six or so early contenders to bring a COVID-19 vaccine to market in the United States.\nUnfortunately, Inovio's phase 2 and 3 studies hit a snag. The FDA placed a partial clinical hold on both phases and requested additional information concerning INO-4800 and the company's Cellectra delivery device. Cellectra uses electrical impulses to open pores in cells to allow plasmids to enter. Though the partial hold on the phase 2 study was lifted, the company has yet to run an all-important phase 3 study and may choose to do so outside the United States. To top things off, the U.S. Department of Defense notified Inovio that it wouldno longer be providing funding for its phase 3 study.\nThere are two very big problems here. First, Inovio is running out of time to become a major player in treating COVID-19. The U.S. vaccination campaign will likely be complete sometime in July, and major players likeJohnson & Johnson can produce up to 3 billion doses for the global market this year. As a reminder, J&J's vaccine is a single-dose treatment.\nThe other potential red flag isInovio's track record. The company may have an intriguing delivery device in Cellectra, as well as nearly a dozen unique compounds in clinical trials, but it's yet to have the FDA approve any of its experimental treatments in four decades.\nWith a number of its studies partnered, it's always possible Inovio could turn itself around. But given its track record, it may be best off avoided.","news_type":1,"symbols_score_info":{}},"isVote":1,"tweetType":1,"viewCount":1198,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":372795857,"gmtCreate":1619240149379,"gmtModify":1704721740773,"author":{"id":"3581987432905129","authorId":"3581987432905129","name":"持仓坚赞","avatar":"https://static.tigerbbs.com/8a3a4e9baafbb73e84285526f19d430d","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581987432905129","authorIdStr":"3581987432905129"},"themes":[],"htmlText":"500%+ in 3 weeks, penny stocks are like gold-digging. You either go broke or go rich.","listText":"500%+ in 3 weeks, penny stocks are like gold-digging. You either go broke or go rich.","text":"500%+ in 3 weeks, penny stocks are like gold-digging. You either go broke or go rich.","images":[{"img":"https://static.tigerbbs.com/6b28f7d9232165382f4ba100976e9d71","width":"750","height":"1788"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/372795857","isVote":1,"tweetType":1,"viewCount":558,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":371720275,"gmtCreate":1618973326097,"gmtModify":1704717710382,"author":{"id":"3581987432905129","authorId":"3581987432905129","name":"持仓坚赞","avatar":"https://static.tigerbbs.com/8a3a4e9baafbb73e84285526f19d430d","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581987432905129","authorIdStr":"3581987432905129"},"themes":[],"htmlText":"No one keeps going without losing steam. For USmarket, just buy &amp; forget till your retirement.","listText":"No one keeps going without losing steam. For USmarket, just buy &amp; forget till your retirement.","text":"No one keeps going without losing steam. For USmarket, just buy & forget till your retirement.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/371720275","repostId":"1195504531","repostType":4,"repost":{"id":"1195504531","kind":"news","pubTimestamp":1618972383,"share":"https://ttm.financial/m/news/1195504531?lang=en_US&edition=fundamental","pubTime":"2021-04-21 10:33","market":"us","language":"en","title":"Opinion: High-momentum stocks have been losing steam and this could be signaling a market top","url":"https://stock-news.laohu8.com/highlight/detail?id=1195504531","media":"Marketwatch","summary":"Change in leadership shows up weeks before the market makes a turn.High-momentum stocks, which are r","content":"<blockquote><b>Change in leadership shows up weeks before the market makes a turn.</b></blockquote><p>High-momentum stocks, which are risky at any time of the market cycle, are particularly so in the weeks prior to a bull market top. That’s the conclusion I reached upon analyzing all U.S. bull markets since 1926. Stocks that are riding a wave of momentum do not crest in unison with the broad market averages. They instead start to lose steam several weeks in advance.</p><p>This is why momentum stocks’ recent behavior is potentially worrisome. Consider the iShares MSCI USA Momentum Factor ETF MTUM, -0.94%, which is the largest ETF that pursues a momentum- strategy in the U.S. stock market. It lagged the S&amp;P 500 SPX, -0.68% by 6.6 percentage points in the first quarter, losing 0.2% versus a 6.4% gain for the index. That’s the worst quarterly performance for the ETF since its inception in 2013.</p><p>This does not guarantee that a market top is imminent, needless to say. It’s worth noting that this ETF has been strong so far this April, even with Monday’s sharp decline. But the ETF’s dismal first-quarter performance nevertheless is ominous.</p><p>Consider what I found upon analyzing high- and low-momentum stocks since 1926, based on data compiled by Dartmouth College professor Ken French. The high-momentum portfolio contained the 10% of stocks with the best trailing-year returns, while the low-momentum portfolio contained the decile with the worst trailing returns. I calculated these two portfolios’ returns in the final weeks of all bull markets in the bull-market calendar maintained by Ned Davis Research.</p><p>Contrary to the usual pattern in which the high-momentum portfolio comes out ahead, the low-momentum portfolio comes out on top in those final weeks, on average.</p><p>Why might that be? My hunch is that market leadership typically changes as bull markets near their end. The stocks that begin to show the greatest relative strength will be those in recession-resistant industries, such as Consumer Staples, as investors look around the curve to anticipate what’s coming down the pike. In contrast, stocks in the most economically sensitive industries (such as Energy) will begin to exhibit relative weakness. This change in leadership can sabotage momentum strategies, which are an implicit bet that what has been strongest in the immediate past will continue to be.</p><p>This failure of momentum near market tops in turn illustrates a broader point: Market tops are gradual, rolling affairs rather than one-day about-faces. So it behooves us to pay attention to the market’s internals rather than to the broad market averages alone. The performance of momentum stock strategies is one such internal.</p><p>Another straw in the wind: The top-performing newsletters I monitor currently are betting that low-momentum stocks will outperform high-momentum issues. I reached this conclusion after constructing two 50-stock lists. The first contained those within the S&amp;P 1500 with the best performance over the last 12 months, and the second contained those with the worst. Currently, none of the top performing stocks is recommended by even two of the top performing newsletters.</p><p>In contrast, three of the worst performing stocks are recommended by more than one of these top-performing newsletters:</p><ul><li>Biogen BIIB, +1.54%</li><li>Merck MRK, +1.17%</li><li>Viatris VTRS, -1.06%</li></ul>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Opinion: High-momentum stocks have been losing steam and this could be signaling a market top</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOpinion: High-momentum stocks have been losing steam and this could be signaling a market top\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-21 10:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/high-momentum-stocks-have-been-losing-steam-and-this-could-signal-a-market-top-11618870480?mod=home-page><strong>Marketwatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Change in leadership shows up weeks before the market makes a turn.High-momentum stocks, which are risky at any time of the market cycle, are particularly so in the weeks prior to a bull market top. ...</p>\n\n<a href=\"https://www.marketwatch.com/story/high-momentum-stocks-have-been-losing-steam-and-this-could-signal-a-market-top-11618870480?mod=home-page\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SPY":"标普500ETF",".DJI":"道琼斯",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index"},"source_url":"https://www.marketwatch.com/story/high-momentum-stocks-have-been-losing-steam-and-this-could-signal-a-market-top-11618870480?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1195504531","content_text":"Change in leadership shows up weeks before the market makes a turn.High-momentum stocks, which are risky at any time of the market cycle, are particularly so in the weeks prior to a bull market top. That’s the conclusion I reached upon analyzing all U.S. bull markets since 1926. Stocks that are riding a wave of momentum do not crest in unison with the broad market averages. They instead start to lose steam several weeks in advance.This is why momentum stocks’ recent behavior is potentially worrisome. Consider the iShares MSCI USA Momentum Factor ETF MTUM, -0.94%, which is the largest ETF that pursues a momentum- strategy in the U.S. stock market. It lagged the S&P 500 SPX, -0.68% by 6.6 percentage points in the first quarter, losing 0.2% versus a 6.4% gain for the index. That’s the worst quarterly performance for the ETF since its inception in 2013.This does not guarantee that a market top is imminent, needless to say. It’s worth noting that this ETF has been strong so far this April, even with Monday’s sharp decline. But the ETF’s dismal first-quarter performance nevertheless is ominous.Consider what I found upon analyzing high- and low-momentum stocks since 1926, based on data compiled by Dartmouth College professor Ken French. The high-momentum portfolio contained the 10% of stocks with the best trailing-year returns, while the low-momentum portfolio contained the decile with the worst trailing returns. I calculated these two portfolios’ returns in the final weeks of all bull markets in the bull-market calendar maintained by Ned Davis Research.Contrary to the usual pattern in which the high-momentum portfolio comes out ahead, the low-momentum portfolio comes out on top in those final weeks, on average.Why might that be? My hunch is that market leadership typically changes as bull markets near their end. The stocks that begin to show the greatest relative strength will be those in recession-resistant industries, such as Consumer Staples, as investors look around the curve to anticipate what’s coming down the pike. In contrast, stocks in the most economically sensitive industries (such as Energy) will begin to exhibit relative weakness. This change in leadership can sabotage momentum strategies, which are an implicit bet that what has been strongest in the immediate past will continue to be.This failure of momentum near market tops in turn illustrates a broader point: Market tops are gradual, rolling affairs rather than one-day about-faces. So it behooves us to pay attention to the market’s internals rather than to the broad market averages alone. The performance of momentum stock strategies is one such internal.Another straw in the wind: The top-performing newsletters I monitor currently are betting that low-momentum stocks will outperform high-momentum issues. I reached this conclusion after constructing two 50-stock lists. The first contained those within the S&P 1500 with the best performance over the last 12 months, and the second contained those with the worst. Currently, none of the top performing stocks is recommended by even two of the top performing newsletters.In contrast, three of the worst performing stocks are recommended by more than one of these top-performing newsletters:Biogen BIIB, +1.54%Merck MRK, +1.17%Viatris VTRS, -1.06%","news_type":1,"symbols_score_info":{".DJI":0.9,"SPY":0.9,".SPX":0.9,".IXIC":0.9}},"isVote":1,"tweetType":1,"viewCount":461,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}